ETH Zurich and AstraZeneca collaborate on sustainable pharmaceutical development goals.
1 report, 1 independent
Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ETH Zurich and AstraZeneca collaborate on sustainable pharmaceutical development goals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ETH Zurich
public research university in Zurich
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- AstraZeneca and Innate Pharma S.A. are collaborating on developing a lead pharmaceutical program.
- Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.
- Chinese pharmaceutical companies are investing heavily in novel technologies while AstraZeneca confirms its Cambridge headquarters and CEO.
- Hoffmann-La Roche, AstraZeneca, and Pfizer are participating in local pharmaceutical production projects in Kazakhstan.